Patents by Inventor Junko Ogawa

Junko Ogawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-COV2 VACCINE VECTOR METHODS AND COMPOSITIONS
    Publication number: 20220048954
    Abstract: Provided herein are recombinant nucleic acids and viral vectors thereof encoding a SARS-CoV-2 spike protein that have been optimized for expression in mammalian cells.
    Type: Application
    Filed: April 26, 2021
    Publication date: February 17, 2022
    Inventors: Gerald Pao, Junko Ogawa
  • COMBINED DRUG FOR TREATING DIABETES
    Publication number: 20090227493
    Abstract: The present invention provides a pharmaceutical composition (preferably a drug for therapeutic and/or prophylactic treatment of diabetes) comprising a GLP-1 receptor agonist and the insulin resistance improving agent 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione, or a pharmacologically acceptable salt thereof, in combination.
    Type: Application
    Filed: May 26, 2006
    Publication date: September 10, 2009
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Ryutaro Nakashima, Junko Ogawa, Akira Okuno
  • Pharmaceutical Composition Containing PPARgamma Agonist
    Publication number: 20090137626
    Abstract: [Object] To provide a highly safe method for treating diabetes that demonstrates superior effects and is capable of inhibiting adverse side effects. [Means for Solution] A pharmaceutical containing a PPAR? agonist, and a pharmaceutical composition in combination with a biguanide agent and a PPAR? agonist.
    Type: Application
    Filed: July 11, 2006
    Publication date: May 28, 2009
    Inventors: Akira Okuno, Taishi Yoshida, Junko Ogawa
  • Antigen protein and nucleic acid coding for said protein
    Patent number: 7070793
    Abstract: To provide a novel antigenic protein and a nucleic acid encoding the antigenic protein, which are useful for prophylaxis, treatment and diagnosis of diseases caused by fungi including Candida albicans. An antigenic protein characterized in that the antigenic protein is recognized by antiserum derived from a mammal having Candida albicans-infection resistance; and a nucleic acid encoding an antigenic protein which is recognized by antiserum derived from a mammal having Candida albicans-infection resistance.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: July 4, 2006
    Assignee: Takara Bio, Inc.
    Inventors: Kazutoh Takesako, Shigetoshi Mizutani, Masahiro Endo, Junko Ogawa, Takashi Okado, Ikunoshin Kato
  • Antigen protein and nucleic acid coding for said protein
    Publication number: 20050276821
    Abstract: To provide a novel antigenic protein and a nucleic acid encoding the antigenic protein, which are useful for prophylaxis, treatment and diagnosis of diseases caused by fungi including Candida albicans. An antigenic protein characterized in that the antigenic protein is recognized by antiserum derived from a mammal having Candida albicans-infection resistance; and a nucleic acid encoding an antigenic protein which is recognized by antiserum derived from a mammal having Candida albicans-infection resistance.
    Type: Application
    Filed: May 3, 2005
    Publication date: December 15, 2005
    Applicant: Takara Bio Inc.
    Inventors: Kazutoh Takesako, Shigetoshi Mizutani, Masahiro Endo, Junko Ogawa, Takashi Okado, Ikunoshin Kato